ECSP11011138A - Formulaciones de desintegración rápida pre-compactadas de compuestos con baja biodisponibilidad oral - Google Patents

Formulaciones de desintegración rápida pre-compactadas de compuestos con baja biodisponibilidad oral

Info

Publication number
ECSP11011138A
ECSP11011138A EC2011011138A ECSP11011138A ECSP11011138A EC SP11011138 A ECSP11011138 A EC SP11011138A EC 2011011138 A EC2011011138 A EC 2011011138A EC SP11011138 A ECSP11011138 A EC SP11011138A EC SP11011138 A ECSP11011138 A EC SP11011138A
Authority
EC
Ecuador
Prior art keywords
compacted
compounds
biod
availability
low oral
Prior art date
Application number
EC2011011138A
Other languages
English (en)
Inventor
Aldo Ket
Jan P Moscwitzer
Yu-San Wu
Tomme Sophie R Van
Henny Kuil
Dewit Lucia M Doesburgh
Original Assignee
Abbott Healthcare Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv
Publication of ECSP11011138A publication Critical patent/ECSP11011138A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención se refiere al campo de la química farmacéutica. Las realizaciones de la presente invención se refieren a y proporcionan formulaciones de desintegración rápida pre-compactadas de compuestos con una baja biodisponibilidad oral.
EC2011011138A 2008-12-19 2011-06-16 Formulaciones de desintegración rápida pre-compactadas de compuestos con baja biodisponibilidad oral ECSP11011138A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13919308P 2008-12-19 2008-12-19
EP08172247 2008-12-19

Publications (1)

Publication Number Publication Date
ECSP11011138A true ECSP11011138A (es) 2011-07-29

Family

ID=40536155

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011011138A ECSP11011138A (es) 2008-12-19 2011-06-16 Formulaciones de desintegración rápida pre-compactadas de compuestos con baja biodisponibilidad oral

Country Status (21)

Country Link
US (1) US20110257158A1 (es)
EP (1) EP2379061B1 (es)
JP (1) JP5669751B2 (es)
KR (1) KR20110104059A (es)
CN (1) CN102395360A (es)
AR (1) AR074689A1 (es)
AU (1) AU2009327068A1 (es)
BR (1) BRPI0922406A2 (es)
CA (1) CA2747345C (es)
CO (1) CO6390098A2 (es)
DO (1) DOP2011000194A (es)
EA (1) EA019147B1 (es)
EC (1) ECSP11011138A (es)
ES (1) ES2393530T3 (es)
IL (1) IL213604A0 (es)
MX (1) MX2011006691A (es)
PE (1) PE20110923A1 (es)
SG (1) SG172246A1 (es)
TW (1) TW201028168A (es)
WO (1) WO2010070057A2 (es)
ZA (1) ZA201104907B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3523252A4 (en) * 2016-10-05 2020-07-01 Boai NKY Medical Holdings Ltd. TABLET COMPOSITIONS CONTAINING CROSSLINKED POLYVINYLPYRROLIDONE AND THEIR USE IN BEVERAGE APPLICATIONS
CA3068936A1 (en) * 2017-07-05 2019-01-10 Novartis Ag Novel pharmaceutical composition
KR102227745B1 (ko) * 2017-12-18 2021-03-15 성균관대학교산학협력단 분해도 제어가 가능한 크라이오젤 스캐폴드 및 상기 스캐폴드에 고형암 미세환경에서 면역억제작용을 제어하는 약물을 로딩한 연성 생체삽입소자

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
EP1070741B1 (de) * 1999-07-19 2008-04-09 fit GmbH Coprozessiertes Polysaccharidprodukt mit vernetztem Polyvinylpyrrolidon
GB0204771D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
JP4523265B2 (ja) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 排尿障害治療用口腔内崩壊製剤
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone
US20070020334A1 (en) * 2005-07-11 2007-01-25 Poul Bertelsen Benzimidazole formulation
US7923026B2 (en) * 2006-10-20 2011-04-12 Solvay Pharmaceuticals B.V. Embedded micellar nanoparticles
ES2646112T3 (es) * 2007-06-06 2017-12-12 Basf Se Formulación farmacéutica para la fabricación de comprimidos que se desintegran rápidamente
EP2164462B1 (de) * 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
DE102007027067A1 (de) * 2007-06-12 2008-12-18 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Vardenafil Hydrochlorid Trihydrat

Also Published As

Publication number Publication date
EP2379061A2 (en) 2011-10-26
JP5669751B2 (ja) 2015-02-18
CA2747345C (en) 2017-05-16
EP2379061B1 (en) 2012-11-14
CN102395360A (zh) 2012-03-28
CA2747345A1 (en) 2010-06-24
MX2011006691A (es) 2011-07-28
IL213604A0 (en) 2011-07-31
US20110257158A1 (en) 2011-10-20
WO2010070057A2 (en) 2010-06-24
TW201028168A (en) 2010-08-01
SG172246A1 (en) 2011-07-28
ES2393530T3 (es) 2012-12-26
BRPI0922406A2 (pt) 2015-12-15
CO6390098A2 (es) 2012-02-29
EA019147B1 (ru) 2014-01-30
AU2009327068A1 (en) 2011-07-14
ZA201104907B (en) 2012-03-28
PE20110923A1 (es) 2012-01-09
WO2010070057A3 (en) 2010-08-19
KR20110104059A (ko) 2011-09-21
DOP2011000194A (es) 2011-07-31
AR074689A1 (es) 2011-02-02
EA201170843A1 (ru) 2012-02-28
JP2012512836A (ja) 2012-06-07

Similar Documents

Publication Publication Date Title
CY1119684T1 (el) Αντι-ιικες ενωσεις
HN2007000407A (es) Compuesto de biaril eter urea
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
HN2011001810A (es) Sintesis de espirikpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de estas.
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
ECSP10010433A (es) Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
ECSP11010834A (es) Formulaciones farmacéuticas que contienen ligandos de receptores de dopamina
DK2508083T3 (da) Biologisk aktivt kosttilskud til profylakse af osteoporose sygdomme
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
SMT201400053B (it) Forme farmaceutiche orali di bendamustina
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
EA201100286A1 (ru) Композиция кветиапина
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
BRPI0818702A2 (pt) Formulação farmacêutica de ácido clavulânico
BRPI0909211A2 (pt) formulação orais e injetáveis de composto de tetraciclina
PA8846401A1 (es) Sinergismo antibiótico
CL2007003593A1 (es) Composicion farmaceutica que comprende fluoresceina pura; procedimiento de preparacion de la fluoresceina.
DOP2013000258A (es) Formulaciones de liberación sostenida de paracetamol
CO6341474A2 (es) Formas solidas de (1r,2s,3r)-1-(2-isoxazol-3-il)-1h-imidazol-4-il) butano-1,2,3,4-tetraol y metodos para su uso
CO7111279A2 (es) Composiciones farmacéuticas orales estables de liberación inmediata que contienen prasugrel
DOP2011000194A (es) Formulaciones de desintegracion rapida pre-compactadas de compuestos con baja biodisponibilidad oral
EA201400683A1 (ru) Стабильные композиции sns-595 и способы их получения